Geneva: The Global Fund to fight acquired immunodeficiency syndrome (Aids), tuberculosis and malaria has approved 94 new grants worth US $2.75 billion over two years to support programmes fighting the three diseases.
It is the eighth time the Global Fund Board approved new proposals in New Delhi and is the largest round in the history of the organisation, well over twice the size of any previous round. It brings the fund's overall portfolio to US $ 14.4 billion in 140 countries.
"These new resources will significantly help the world in achieving global targets such as universal access to Aids treatment and prevention, and cutting the number of deaths from tuberculosis and malaria by half by 2015," the Global Fund Board Chair Rajat Gupta said.
The Global Fund Executive Director of the Michel Kazatchkine said that this exceptional expression of increased demand requires a renewed resource mobilisation effort.
"We have a fantastic message to bring back to the rich nations of the world—programmes to fight these three diseases save lives, reduce disease burdens, and strengthen health systems. We are asking you for resources for an effective way to reduce the gap between rich and poor and build a better and safer world,” Kazatchkine said.
Of the approved proposals, the majority of resources go to malaria programmes accounting for 51 per cent. Proposals for Aids and tuberculosis account for 38 per cent and 11 per cent, respectively, of the approved funding.
Ninety per cent of the approved grants today are for low-income countries, with the majority of resources (77 per cent) for Africa and the Middle East.
Asia and the Western Pacific will receive 14 per cent of the newly approved funding, Latin America and the Caribbean six per cent, and Eastern Europe and Central Asia six per cent. —iGovernment Bureau